Site Search

DEUTSCH All Languages

Companies in the News

Pronova BioPharma ASA (OSL:PRON) Pronova To Host A Webcast Regarding The GISSI-HF Study 1 September

Pronova BioPharma ASA (OSL:PRON) 25 August, 2008, Lysaker, Norway: Pronova BioPharma ASA (OSE: PRON.OL) will host a webcast on Monday 1 September where top-line data from the GISSI-HF study will be presented.

Dr. Roberto Marchioli from Laboratory of Clinical Epidemiology of Cardiovascular Disease, Consorzio Mario Negri Su will present top-line data from the GISS-HF study at 15:00 CET. The presentation will be held at NH München Neue Messe, Eggenfeldener Strasse 100, D-81929 Munich (Germany)

The presentation will also be webcasted live over the Internet and can be accessed from www.pronova.com. The company will host a telephone conference which opens up for Q&A to Dr. Marchioli immediately after the presentation.

To participate, please dial: Norway Toll Free: 800 19640 UK Toll Free : 0800 028 1299 UK Toll/International Dial In: +44 (0) 20 7806 1968 USA Toll Free: 1888 935 4577

The following conference ID is required: 4403377

For further information, please contact: Hilde H. Steineger, Head of Investor Relations Tel +47 22 53 49 09 IR@pronova.com

Pronova BioPharma ASA

http://www.pronova.com

ISIN: NO0010382021

Stock Identifier: XOSL.PRON

Verbundene Unternehmen

Pronova BioPharma ASA

ABN Newswire Diese Seite wurde besucht: (letzten 7 Tagen: 1) (letzten 30 Tagen: 9) (seit Veröffentlichung: 623)